104 related articles for article (PubMed ID: 2025578)
1. Increased expression of the c-myc gene may be related to the aggressive transformation of human myeloma cells.
Nobuyoshi M; Kawano M; Tanaka H; Ishikawa H; Tanabe O; Iwato K; Asaoku H; Sakai A; Kuramoto A
Br J Haematol; 1991 Apr; 77(4):523-8. PubMed ID: 2025578
[TBL] [Abstract][Full Text] [Related]
2. Expression of myc-family genes in established human multiple myeloma cell lines: L-myc but not c-myc gene expression in the U-266 myeloma cell line.
Jernberg-Wiklund H; Pettersson M; Larsson LG; Anton R; Nilsson K
Int J Cancer; 1992 Apr; 51(1):116-23. PubMed ID: 1563831
[TBL] [Abstract][Full Text] [Related]
3. Molecular alterations of IL-6R, lck and c-myc genes in transforming monoclonal gammopathies of undetermined significance.
Gernone A; Dammacco F
Br J Haematol; 1996 Jun; 93(3):623-31. PubMed ID: 8652383
[TBL] [Abstract][Full Text] [Related]
4. Amplification of the c-myc and the pvt-like region in human multiple myeloma.
Bakkus MH; Brakel-van Peer KM; Michiels JJ; van 't Veer MB; Benner R
Oncogene; 1990 Sep; 5(9):1359-64. PubMed ID: 2216459
[TBL] [Abstract][Full Text] [Related]
5. Expression of the c-myc proto-oncogene in multiple myeloma and chronic lymphocytic leukemia: an in situ analysis.
Greil R; Fasching B; Loidl P; Huber H
Blood; 1991 Jul; 78(1):180-91. PubMed ID: 2070052
[TBL] [Abstract][Full Text] [Related]
6. Elevated c-myc messenger RNA in multiple myeloma cell lines.
Fourney R; Palmer M; Ng A; Dietrich K; Belch A; Paterson M; Brox L
Dis Markers; 1990; 8(3):117-24. PubMed ID: 1980237
[TBL] [Abstract][Full Text] [Related]
7. Alteration and abnormal expression of the c-myc oncogene in human multiple myeloma.
Selvanayagam P; Blick M; Narni F; van Tuinen P; Ledbetter DH; Alexanian R; Saunders GF; Barlogie B
Blood; 1988 Jan; 71(1):30-5. PubMed ID: 3275475
[TBL] [Abstract][Full Text] [Related]
8. Human homologue of Moloney leukemia virus integration-4 locus (MLVI-4), located 20 kilobases 3' of the myc gene, is rearranged in multiple myelomas.
Palumbo AP; Boccadoro M; Battaglio S; Corradini P; Tsichlis PN; Huebner K; Pileri A; Croce CM
Cancer Res; 1990 Oct; 50(20):6478-82. PubMed ID: 2208106
[TBL] [Abstract][Full Text] [Related]
9. Effects of sodium butyrate on the rearranged c-myc expression in mouse plasmacytoma cells.
Kondoh N; Oikawa T; Satoh C; Kuzumaki N
Exp Cell Res; 1991 Sep; 196(1):146-9. PubMed ID: 1879469
[TBL] [Abstract][Full Text] [Related]
10. Extinction of expression of the translocated myc gene in somatic cell hybrids between mouse myeloma and L-cells.
Greenberg A; Hijazzi M; Sharir H; Cohen L; Bergman Y; Ber R; Laskov R
Int J Cancer; 1989 Jan; 43(1):87-92. PubMed ID: 2492015
[TBL] [Abstract][Full Text] [Related]
11. Altered myc gene transcription and intron-induced stabilization of myc RNAs in two mouse plasmacytomas.
Bauer SR; Piechaczyk M; Nordan RP; Owens JD; Nepveu A; Marcu KB; Mushinski JF
Oncogene; 1989 May; 4(5):615-23. PubMed ID: 2657576
[TBL] [Abstract][Full Text] [Related]
12. Identification of a second transforming gene, rasn, in a human multiple myeloma line with a rearranged c-myc allele.
Ernst TJ; Gazdar A; Ritz J; Shipp MA
Blood; 1988 Oct; 72(4):1163-7. PubMed ID: 3048435
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling reveals different pathways related to Abl and other genes that cooperate with c-Myc in a model of plasma cell neoplasia.
Park ES; Shaughnessy JD; Gupta S; Wang H; Lee JS; Woo HG; Zhan F; Owens JD; Potter M; Janz S; Mushinski JF
BMC Genomics; 2007 Aug; 8():302. PubMed ID: 17764563
[TBL] [Abstract][Full Text] [Related]
14. Investigation of aberrant translational control of c-myc in cell lines derived from patients with multiple myeloma.
Willis AE; Paulin FE; West MJ; Whitney RL
Curr Top Microbiol Immunol; 1997; 224():269-76. PubMed ID: 9308251
[TBL] [Abstract][Full Text] [Related]
15. The IL-6 gene but not the IL-6 receptor gene is occasionally rearranged in patients with multiple myeloma.
Fiedler W; Weh HJ; Suciu E; Wittlief C; Stocking C; Hossfeld DK
Leukemia; 1990 Jul; 4(7):462-5. PubMed ID: 1695702
[TBL] [Abstract][Full Text] [Related]
16. Identification of c-myc promoter-binding protein and X-box binding protein 1 as interleukin-6 target genes in human multiple myeloma cells.
Wen XY; Stewart AK; Sooknanan RR; Henderson G; Hawley TS; Reimold AM; Glimcher LH; Baumann H; Malek LT; Hawley RG
Int J Oncol; 1999 Jul; 15(1):173-8. PubMed ID: 10375612
[TBL] [Abstract][Full Text] [Related]
17. Hemopoietic neoplasms in lethally irradiated mice repopulated with bone marrow cells carrying the human c-myc oncogene: a repopulation assay.
Hirabayashi Y; Inoue T; Suda Y; Aizawa S; Ikawa Y; Kanisawa M
Exp Hematol; 1992 Feb; 20(2):167-72. PubMed ID: 1544384
[TBL] [Abstract][Full Text] [Related]
18. Aberrant translational control of the c-myc gene in multiple myeloma.
Paulin FE; West MJ; Sullivan NF; Whitney RL; Lyne L; Willis AE
Oncogene; 1996 Aug; 13(3):505-13. PubMed ID: 8760292
[TBL] [Abstract][Full Text] [Related]
19. A transgenic mouse model of plasma cell malignancy shows phenotypic, cytogenetic, and gene expression heterogeneity similar to human multiple myeloma.
Boylan KL; Gosse MA; Staggs SE; Janz S; Grindle S; Kansas GS; Van Ness BG
Cancer Res; 2007 May; 67(9):4069-78. PubMed ID: 17483317
[TBL] [Abstract][Full Text] [Related]
20. Clonal rearrangement of the beta-T cell receptor gene in multiple myeloma.
Berenson J; Lichtenstein A
Leukemia; 1989 Feb; 3(2):133-6. PubMed ID: 2536128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
